Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodore S Hong

Showing results (191-200 of 306) with videos related to

Pageof 31
Sort By:
International Journal of Radiation Oncology, Biology, Physics|June 28, 2014
Interobserver variability in target definition for hepatocellular carcinoma with and without portal vein thrombus: radiation therapy oncology group consensus guidelinesTheodore S Hong, Walter R Bosch, Sunil Krishnan, et al.
Annals of Surgical Oncology|October 3, 2018
Are Staging Computed Tomography (CT) Scans of the Chest Necessary in Pancreatic Adenocarcinoma?Winta T Mehtsun, Fallon E Chipidza, Carlos Fernández-Del Castillo, et al.
Practical Radiation Oncology|November 27, 2014
Clinical and treatment factors associated with vaginal stenosis after definitive chemoradiation for anal canal cancerKristina Mirabeau-Beale, Theodore S Hong, Andrzej Niemierko, et al.
Cancer Research|February 17, 2017
Radiation Resistance in KRAS-Mutated Lung Cancer Is Enabled by Stem-like Properties Mediated by an Osteopontin-EGFR PathwayMeng Wang, Jing Han, Lynnette Marcar, et al.
Annals of Surgical Oncology|December 25, 2019
Hypofractionated Radiation Therapy for Unresectable/Locally Recurrent Intrahepatic CholangiocarcinomaAlicia C Smart, Lipika Goyal, Nora Horick, et al.
The Oncologist|February 14, 2019
High IDO1 Expression Is Associated with Poor Outcome in Patients with Anal Cancer Treated with Definitive ChemoradiotherapyDevarati Mitra, Nora K Horick, Diane G Brackett, et al.
NPJ Precision Oncology|October 31, 2018
Pretreatment plasma HGF as potential biomarker for susceptibility to radiation-induced liver dysfunction after radiotherapyTheodore S Hong, Clemens Grassberger, Beow Y Yeap, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2019
Integrative Molecular Characterization of Resistance to Neoadjuvant Chemoradiation in Rectal CancerSophia C Kamran, Jochen K Lennerz, Claire A Margolis, et al.
The Oncologist|August 23, 2020
Chemoradiation-Related Lymphopenia and Its Association with Survival in Patients with Squamous Cell Carcinoma of the Anal CanalGrace Lee, Daniel W Kim, Vinayak Muralidhar, et al.
Brachytherapy|May 16, 2019
The American Brachytherapy Society consensus statement on intraoperative radiation therapyMartin C Tom, Nikhil Joshi, Frank Vicini, et al.
Pageof 31

Showing results (191-200 of 306) with videos related to

Sort By:
Pageof 31
International Journal of Radiation Oncology, Biology, Physics|June 28, 2014
Interobserver variability in target definition for hepatocellular carcinoma with and without portal vein thrombus: radiation therapy oncology group consensus guidelinesTheodore S Hong, Walter R Bosch, Sunil Krishnan, et al.
Annals of Surgical Oncology|October 3, 2018
Are Staging Computed Tomography (CT) Scans of the Chest Necessary in Pancreatic Adenocarcinoma?Winta T Mehtsun, Fallon E Chipidza, Carlos Fernández-Del Castillo, et al.
Practical Radiation Oncology|November 27, 2014
Clinical and treatment factors associated with vaginal stenosis after definitive chemoradiation for anal canal cancerKristina Mirabeau-Beale, Theodore S Hong, Andrzej Niemierko, et al.
Cancer Research|February 17, 2017
Radiation Resistance in KRAS-Mutated Lung Cancer Is Enabled by Stem-like Properties Mediated by an Osteopontin-EGFR PathwayMeng Wang, Jing Han, Lynnette Marcar, et al.
Annals of Surgical Oncology|December 25, 2019
Hypofractionated Radiation Therapy for Unresectable/Locally Recurrent Intrahepatic CholangiocarcinomaAlicia C Smart, Lipika Goyal, Nora Horick, et al.
The Oncologist|February 14, 2019
High IDO1 Expression Is Associated with Poor Outcome in Patients with Anal Cancer Treated with Definitive ChemoradiotherapyDevarati Mitra, Nora K Horick, Diane G Brackett, et al.
NPJ Precision Oncology|October 31, 2018
Pretreatment plasma HGF as potential biomarker for susceptibility to radiation-induced liver dysfunction after radiotherapyTheodore S Hong, Clemens Grassberger, Beow Y Yeap, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2019
Integrative Molecular Characterization of Resistance to Neoadjuvant Chemoradiation in Rectal CancerSophia C Kamran, Jochen K Lennerz, Claire A Margolis, et al.
The Oncologist|August 23, 2020
Chemoradiation-Related Lymphopenia and Its Association with Survival in Patients with Squamous Cell Carcinoma of the Anal CanalGrace Lee, Daniel W Kim, Vinayak Muralidhar, et al.
Brachytherapy|May 16, 2019
The American Brachytherapy Society consensus statement on intraoperative radiation therapyMartin C Tom, Nikhil Joshi, Frank Vicini, et al.
Pageof 31